Leap Therapeutics Reports Second Quarter 2022 Financial Results
/PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported...
United States United Kingdom New Zealand Matthew Deyoung Douglase Onsi American Society Of Clinical Oncology
Source: prnewswire.com